Home / Publications / Antimicrobial screening of a historical collection of over 140 000 small molecules

Antimicrobial screening of a historical collection of over 140 000 small molecules

Victor Vladimirovich Semenov 1
Victor Vladimirovich Semenov
Mikhail Mikhailovich Raihstat 1
Mikhail Mikhailovich Raihstat
Leonid Dmitrievich Konyushkin 1
Leonid Dmitrievich Konyushkin
Roman V Semenov 1
Roman V Semenov
Mark A.T. Blaskovich 2
Mark A.T. Blaskovich
Johannes Zuegg 2
Johannes Zuegg
Alysha G Elliott 2
Alysha G Elliott
Karl A Hansford 2
Karl A Hansford
Matthew A Cooper 2
Matthew A Cooper
Published 2021-07-07
CommunicationVolume 31, Issue 4, 484-487
12
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Semenov V. V. et al. Antimicrobial screening of a historical collection of over 140 000 small molecules // Mendeleev Communications. 2021. Vol. 31. No. 4. pp. 484-487.
GOST all authors (up to 50) Copy
Semenov V. V., Raihstat M. M., Konyushkin L. D., Semenov R. V., Blaskovich M. A., Zuegg J., Elliott A. G., Hansford K. A., Cooper M. A. Antimicrobial screening of a historical collection of over 140 000 small molecules // Mendeleev Communications. 2021. Vol. 31. No. 4. pp. 484-487.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2021.07.015
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2021.07.015
TI - Antimicrobial screening of a historical collection of over 140 000 small molecules
T2 - Mendeleev Communications
AU - Semenov, Victor Vladimirovich
AU - Raihstat, Mikhail Mikhailovich
AU - Konyushkin, Leonid Dmitrievich
AU - Semenov, Roman V
AU - Blaskovich, Mark A.T.
AU - Zuegg, Johannes
AU - Elliott, Alysha G
AU - Hansford, Karl A
AU - Cooper, Matthew A
PY - 2021
DA - 2021/07/07
PB - Mendeleev Communications
SP - 484-487
IS - 4
VL - 31
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Semenov,
author = {Victor Vladimirovich Semenov and Mikhail Mikhailovich Raihstat and Leonid Dmitrievich Konyushkin and Roman V Semenov and Mark A.T. Blaskovich and Johannes Zuegg and Alysha G Elliott and Karl A Hansford and Matthew A Cooper},
title = {Antimicrobial screening of a historical collection of over 140 000 small molecules},
journal = {Mendeleev Communications},
year = {2021},
volume = {31},
publisher = {Mendeleev Communications},
month = {Jul},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2021.07.015},
number = {4},
pages = {484--487},
doi = {10.1016/j.mencom.2021.07.015}
}
MLA
Cite this
MLA Copy
Semenov, Victor Vladimirovich, et al. “Antimicrobial screening of a historical collection of over 140 000 small molecules.” Mendeleev Communications, vol. 31, no. 4, Jul. 2021, pp. 484-487. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2021.07.015.

Abstract

Most of the chemical compound collection (currently about 200 000), assembled at the N. D. Zelinsky Institute of Organic Chemistry over the past 30 years, has been screened for antimicrobial activity against five ESKAPE pathogens and two fungi at the University of Queensland on a charitable basis. A total of 2517 active molecules (MIC ≤ 32 μg ml–1) were found, of which about 10% are active at very low concentrations (MIC ≤ 1 μg ml–1). Structures of 142 012 compounds and experimental data on their antimicrobial activity are publicly available through the demo version of the CheD software and the public database of the Community for Open Antimicrobial Drug Discovery.

References

1.
Antibiotic/Antimicrobial Resistance, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, March 13, 2020. https://www.cdc.gov/drugresistance/about.html.
2.
CDC. Antibiotic Resistance Threats in the United States, 2019, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, December, 2019. https://www.cdc.gov/drugresistance/ pdf/threats-report/2019-ar-threats-report-508.pdf.
3.
10.1016/j.mencom.2021.07.015_b0015
Cooper
Nature, 2011
4.
Analysis of the clinical antibacterial and antituberculosis pipeline
Theuretzbacher U., Gottwalt S., Beyer P., Butler M., Czaplewski L., Lienhardt C., Moja L., Paul M., Paulin S., Rex J.H., Silver L.L., Spigelman M., Thwaites G.E., Paccaud J., Harbarth S., et. al.
The Lancet Infectious Diseases, 2019
5.
Antibiotics in the clinical pipeline in October 2019
Butler M.S., Paterson D.L.
Journal of Antibiotics, 2020
6.
The small-molecule antibiotics pipeline: 2014–2018
Lepore C., Silver L., Theuretzbacher U., Thomas J., Visi D.
Nature Reviews Drug Discovery, 2019
7.
10.1016/j.mencom.2021.07.015_b0035
Shlaes
Antimicrob. Agents Chemother., 2020
8.
Screening Library Collection Database, Chemical Block, 2021. http://www.chemical-block.com/.
9.
CheD:  Chemical Database Compilation Tool, Internet Server, and Client for SQL Servers
Trepalin S.V., Yarkov A.V.
Journal of Chemical Information and Computer Sciences, 2000
10.
How to Stimulate and Facilitate Early Stage Antibiotic Discovery
Zuegg J., Hansford K.A., Elliott A.G., Cooper M.A., Blaskovich M.A.
ACS Infectious Diseases, 2020
11.
10.1016/j.mencom.2021.07.015_b0055
Blaskovich
Dis., 2015
12.
Wellcome Trust. https://wellcome.org.
13.
A call to arms
Nature Reviews Drug Discovery, 2006
14.
The antifungal pipeline: a reality check
Perfect J.R.
Nature Reviews Drug Discovery, 2017
15.
Free Compound Screening for Antimicrobial Activity, Community for Open Antimicrobial Drug Discovery, 2018. https://www.co-add.org/ content/facilities.
16.
CheD-program, Antimicrobal Screening Database, Chemical Database. https://www.zelinsky.ru/files/public/ChedDemoCBI.zip.
17.
Open-access Antimicrobial Screening Database, Community for Open Antimicrobial Drug Discovery, January, 2021. https://db.co-add.org.
18.
CO-ADD WorkflowScreening.pdf, Community for Open Antimicrobial Drug Discovery, May, 2016. https://www.co-add.org/file/co-add-workflowscreeningpdf-0.